
The information contained in this announcement is restricted and is not for publication, release or distribution in
("Impact" or the "Company" or, together with its subsidiaries, the "Group")
DIVIDEND DECLARATION
The Board has today declared the Company's first interim dividend for the year ending
This is in line with the Company's target annual dividend for the year to
The Company expects to report the Group's NAV for the quarter to
Notes:
(1) This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.
FOR FURTHER INFORMATION, PLEASE CONTACT:
|
|
Via H/Advisors Maitland |
|
|
|
|
|
|
David Yaldron |
|
|
|
|
|
|
|
+44 20 7029 8000 |
|
|
|
|
|
|
|
|
|
|
|
+44 20 3100 0000 |
|
|
|
|
|
|
|
|
|
H/Advisors Maitland (Communications advisor) |
|
|
|
|
+44 7747 113 930 |
|
|
+44 20 7379 5151 |
|
|
+44 20 7379 5151 |
The Company's LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at www.impactreit.uk.
NOTES:
The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of
The Company's dividend policy is to maintain a progressive dividend that is covered by adjusted earnings.
On this basis, the target total dividend for the year ending
The Group's Ordinary Shares were admitted to trading on the main market of the
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the